Related Experiment Video

Updated: Aug 13, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas

L Barzon1, M Zanusso, F Colombo

  • 1Department of Histology, Microbiology and Medical Biotechnologies, University of Padova, Padova, and Division of Neurosurgery, San Bortolo Hospital, Vicenza, Italy. luisa.barzon@unipd.it

Cancer Gene Therapy
|January 18, 2006
PubMed

Insights

New insights into brain tumor genetics are driving innovative therapies like gene therapy, virotherapy, and vaccination for malignant gliomas. These novel approaches offer hope for improving patient prognosis beyond traditional treatments.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Malignant gliomas have a poor prognosis despite current surgical and adjuvant therapies.
  • Recent advances in understanding brain tumor genetics and biology are crucial.
  • This knowledge fuels the development of novel treatment strategies.

Purpose of the Study:

  • To critically discuss innovative therapeutic modalities for malignant gliomas.
  • To evaluate gene therapy, virotherapy, and vaccination approaches.
  • To provide perspectives on future research directions in brain tumor treatment.

Main Methods:

  • Review and critical discussion of existing literature on novel glioma therapies.
  • Analysis of clinical trial data for gene therapy, virotherapy, and vaccination.
  • Comparative evaluation of the advantages and disadvantages of each modality.

Main Results:

  • Emerging therapeutic strategies show promise in preclinical and early clinical settings.
  • Gene therapy, virotherapy, and vaccination represent a paradigm shift in glioma treatment.
  • Each modality presents unique benefits and challenges requiring further investigation.

Conclusions:

  • Understanding glioma's molecular basis is key to developing effective treatments.
  • Innovative therapies offer potential improvements over conventional approaches.
  • Further research and clinical trials are essential to optimize these novel treatments for malignant gliomas.

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.